Third Harmonic Bio Analyst Ratings
Third Harmonic Bio Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 12.18% | Morgan Stanley | $5 → $7 | Maintains | Equal-Weight |
| 12/16/2022 | -19.87% | Morgan Stanley | $34 → $5 | Downgrades | Overweight → Equal-Weight |
| 12/16/2022 | -42.31% | Jefferies | $30 → $3.6 | Downgrades | Buy → Hold |
| 10/10/2022 | 380.77% | Jefferies | → $30 | Initiates Coverage On | → Buy |
| 10/10/2022 | 444.87% | Morgan Stanley | → $34 | Initiates Coverage On | → Overweight |
| 10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
What is the target price for Third Harmonic Bio (THRD)?
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Morgan Stanley on August 11, 2023. The analyst firm set a price target for $7.00 expecting THRD to rise to within 12 months (a possible 12.18% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Third Harmonic Bio (THRD)?
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Morgan Stanley, and Third Harmonic Bio maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Third Harmonic Bio (THRD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
Is the Analyst Rating Third Harmonic Bio (THRD) correct?
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a maintained with a price target of $5.00 to $7.00. The current price Third Harmonic Bio (THRD) is trading at is $6.24, which is within the analyst's predicted range.
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 12.18% | Morgan Stanley | $5 → $7 | Maintains | Equal-Weight |
| 12/16/2022 | -19.87% | Morgan Stanley | $34 → $5 | Downgrades | Overweight → Equal-Weight |
| 12/16/2022 | -42.31% | Jefferies | $30 → $3.6 | Downgrades | Buy → Hold |
| 10/10/2022 | 380.77% | Jefferies | → $30 | Initiates Coverage On | → Buy |
| 10/10/2022 | 444.87% | Morgan Stanley | → $34 | Initiates Coverage On | → Overweight |
| 10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月11日 | 12.18% | 摩根士丹利 | $5→$7 | 維護 | 等重 |
| 12/16/2022 | -19.87% | 摩根士丹利 | $34→$5 | 評級下調 | 超重→等重 |
| 12/16/2022 | -42.31% | 傑富瑞 | $30→$3.6 | 評級下調 | 購買→Hold |
| 2022年10月10日 | 380.77% | 傑富瑞 | →$30 | 開始承保 | →購買 |
| 2022年10月10日 | 444.87% | 摩根士丹利 | →$34 | 開始承保 | →超重 |
| 2022年10月10日 | - | 考恩公司 | 開始承保 | →跑贏大盤 |
What is the target price for Third Harmonic Bio (THRD)?
Third Harmonic Bio(THRD)的目標價格是多少？
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Morgan Stanley on August 11, 2023. The analyst firm set a price target for $7.00 expecting THRD to rise to within 12 months (a possible 12.18% upside). 6 analyst firms have reported ratings in the last year.
三和生物(納斯達克：TRD)的最新目標價是由摩根士丹利在2023年8月11日報道的。這家分析公司將目標價定為7.00美元，預計THRD將在12個月內升至(可能上漲12.18%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Third Harmonic Bio (THRD)?
分析師對Third Harmonic Bio(THRD)的最新評級是多少？
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Morgan Stanley, and Third Harmonic Bio maintained their equal-weight rating.
三和生物(納斯達克：TRAD)最新分析師評級由摩根士丹利提供，三和生物維持等權重評級。
When is the next analyst rating going to be posted or updated for Third Harmonic Bio (THRD)?
下一次分析師對Third Harmonic Bio(THRD)的評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Third Harmonic Bio的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Third Harmonic Bio的最後一次評級是在2023年8月11日提交的，所以你應該預計下一次評級將在2024年8月11日左右提供。
Is the Analyst Rating Third Harmonic Bio (THRD) correct?
分析師對Third Harmonic Bio(THRD)的評級正確嗎？
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a maintained with a price target of $5.00 to $7.00. The current price Third Harmonic Bio (THRD) is trading at is $6.24, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Third Harmonic Bio(THRD)評級保持不變，目標價在5.00美元至7.00美元之間。目前Third Harmonic Bio(THRD)的交易價格為6.24美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧